Live Breaking News & Updates on Kiniksa Pharmaceuticals Stock Performance

Stay updated with breaking news from Kiniksa pharmaceuticals stock performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $30.00

Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) had its price target raised by Evercore ISI from $25.00 to $30.00 in a research report report published on Wednesday morning, Benzinga reports. Evercore ISI currently has an outperform rating on the stock. A number of other equities research analysts have also commented on KNSA. Wedbush restated an outperform […] ....

Michaelr Megna , Advisors Inc , Capital Management Inc , Kiniksa Pharmaceuticals , News Ratings For Kiniksa Pharmaceuticals Daily , Securities Exchange Commission , Kiniksa Pharmaceuticals Stock Performance , China Universal Asset Management Co , Kiniksa Pharmaceuticals Company Profile , Dynamic Technology Lab Private Ltd , Victory Capital Management Inc , Hedge Funds Weigh In On Kiniksa Pharmaceuticals , Kiniksa Pharmaceuticals Ltd , Free Report , Get Free Report , Exchange Commission , Universal Asset Management , Capital Management , Technology Lab Private Ltd , Kiniksa Pharmaceuticals Daily , Nasdaq Knsa , Boost Price Target , Evercore Isi ,

Evercore ISI Boosts Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00

Evercore ISI Boosts Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Michaelr Megna , Kiniksa Pharmaceuticals Stock Performance , Kiniksa Pharmaceuticals Ltd , Allspring Global Investments Holdings , Hennion Walsh Asset Management Inc , Securities Exchange Commission , Institutional Trading Of Kiniksa Pharmaceuticals , Kiniksa Pharmaceuticals Company Profile , Kiniksa Pharmaceuticals , News Ratings For Kiniksa Pharmaceuticals Daily , Parkman Healthcare Partners , Granahan Investment Management , Opaleye Management Inc , Get Free Report , Exchange Commission , Global Investments Holdings , Walsh Asset Management , Healthcare Partners , Investment Management , Kiniksa Pharmaceuticals Daily ,

Evercore ISI Increases Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00

Evercore ISI Increases Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Michaelr Megna , Sanjk Patel , Principal Financial Group Inc , Insider Transactions At Kiniksa Pharmaceuticals , Securities Exchange Commission , Linden Thomas Advisory Services , China Universal Asset Management Co , Connor Clark Lunn Investment Management Ltd , Kiniksa Pharmaceuticals Stock Performance , Kiniksa Pharmaceuticals Ltd , Alps Advisors Inc , Institutional Investors Weigh In On Kiniksa Pharmaceuticals , News Ratings For Kiniksa Pharmaceuticals Daily , Kiniksa Pharmaceuticals , Get Free Report , Exchange Commission , Universal Asset Management , Lunn Investment Management , Financial Group , Thomas Advisory Services , Alps Advisors , Kiniksa Pharmaceuticals Daily ,

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Sets New 1-Year High at $20.94

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $20.94 and last traded at $20.83, with a volume of 197612 shares traded. The stock had previously closed at $20.16. Analyst Ratings Changes KNSA has been the topic of […] ....

Johnf Paolini , Michaelr Megna , Tower Research Capital , Altshuler Shaham Ltd , News Ratings For Kiniksa Pharmaceuticals Daily , Lazard Asset Management , Kiniksa Pharmaceuticals Stock Performance , Kiniksa Pharmaceuticals Ltd , Royal Bank , Securities Exchange Commission , Advisors Inc , Kiniksa Pharmaceuticals , Get Free Report , Exchange Commission , Research Capital , Asset Management , Shaham Ltd , Kiniksa Pharmaceuticals Daily , Nasdaq Knsa ,

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Sets New 1-Year High at $20.94

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $20.94 and last traded at $20.83, with a volume of 197612 shares traded. The stock had previously closed at $20.16. Analyst Ratings Changes KNSA has been the topic of […] ....

Michaelr Megna , Johnf Paolini , Advisors Inc , Kiniksa Pharmaceuticals , Securities Exchange Commission , Kiniksa Pharmaceuticals Stock Performance , Royal Bank , Kiniksa Pharmaceuticals Ltd , Lazard Asset Management , Altshuler Shaham Ltd , News Ratings For Kiniksa Pharmaceuticals Daily , Tower Research Capital , Get Free Report , Exchange Commission , Research Capital , Asset Management , Shaham Ltd , Kiniksa Pharmaceuticals Daily ,